Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

34.32
Delayed Data
As of Apr 29
 +0.03 / +0.09%
Today’s Change
20.03
Today|||52-Week Range
60.79
-36.20%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close34.29
Today’s open34.49
Day’s range33.77 - 35.08
Volume308,800
Average volume (3 months)546,756
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-11.09%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.15+0.35%
INVAInnoviva Inc-0.01-0.08%
CXRXConcordia Healthcare...-1.40-4.58%
EBSEmergent BioSolution...-0.68-1.73%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs